ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum.
about
E-type prostanoid receptor 4 (EP4) in disease and therapyClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetAssociation between Hsp90 and the ClC-2 chloride channel upregulates channel functionLubiprostone stimulates duodenal bicarbonate secretion in ratsOral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.Research and progress on ClC‑2 (Review).Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair.Loss of EP2 receptor subtype in colonic cells compromise epithelial barrier integrity by altering claudin-4A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosaPorcine models of digestive disease: the future of large animal translational research.Genetic Ablation of the ClC-2 Cl- Channel Disrupts Mouse Gastric Parietal Cell Acid Secretion.Clcn2 encodes the hyperpolarization-activated chloride channel in the ducts of mouse salivary glandsLipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways.Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine.Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis.Chloride channelopathies of ClC-2.Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research.The use of nonsteroidal anti-inflammatory drugs in critically ill horses.Chloride channel ClC- 2 enhances intestinal epithelial tight junction barrier function via regulation of caveolin-1 and caveolar trafficking of occludin.Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.Gastro protective properties of the novel prostone SPI-8811 against acid-injured porcine mucosa.A synthetic prostone activates apical chloride channels in A6 epithelial cells.Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin.ClC-2 regulates mucosal barrier function associated with structural changes to the villus and epithelial tight junction.Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis.Prostaglandin-mediated inhibition of Na+/H+ exchanger isoform 2 stimulates recovery of barrier function in ischemia-injured intestine.
P2860
Q26851156-26CEF6AD-C1A4-419F-9B7A-E7D03BEED65AQ28066092-3730D8CB-4E95-47F6-9C21-399C34F20E52Q28263936-D36F231E-05A6-4C66-BCA9-7EA6A5FD0FC9Q28572915-30C28A11-44DE-46AD-BDB4-1859E6841139Q33515113-FCAC83AB-2D37-4B3C-BB9D-4331B45B966FQ33828111-9DE1FD3C-F163-47E3-B555-6AB0B4A34868Q33996708-63CAC1F1-20FE-4612-B9E8-90A2C135B726Q35420561-35717E25-53C2-4533-9C2C-5893B96FF9C1Q35664952-A301F031-1C29-4369-8E3D-7AAB297EDC91Q35691021-EA1D8F16-D7CB-4924-98E3-2FF1AE37D8D8Q35778280-B015A989-9038-467C-9F12-504E38917206Q36977072-C9B44955-D41E-4E93-AF93-D0B298CAF320Q37138755-3F69FDCE-63D6-4EC1-AE83-773B9D0B58F0Q37190237-F3CD6A79-CA85-45BC-909B-4A1695BC5331Q37383155-CC28F9A8-759F-4605-9219-FA74EF9630EFQ37430683-F42E18EC-96BD-4EB1-9042-A16C76724C54Q37535425-A88C6C0F-07A3-4EC0-9440-1034712CB755Q37704523-4F2E924E-E8B7-4422-AD7B-D91E71F63DA5Q37869371-F64C7117-960A-4CB2-B2FD-07EAF7B12C0DQ38029718-1808C776-4010-4F29-A98F-572D582BD05CQ38175457-453E814A-DB3C-4F7D-BEBD-AE3840D8C5D2Q38270128-C5C06AC9-2E9A-43C2-B19F-AC9C8EC1E326Q38292907-AE145DF2-8612-4ED7-828F-49C333C46C92Q38717938-EF91159D-92DD-4509-82F8-61A64F4ECC49Q38739653-76774D13-9234-46ED-AEC7-237FEC6DBFF0Q41815252-6BA6F145-38FB-4A9E-8057-7378AE841F00Q42054094-608A49B6-3995-4288-BE45-94C2F0146203Q42495161-FE0F4C5E-39DF-4397-A29E-CB715155213EQ43057921-1AEF0FFE-5261-4C32-A721-7955BD038675Q44859490-D274AA29-DB1A-48A5-990D-1B4362CF916AQ44865366-D3B962B6-9704-4214-A68A-E6513B75B191
P2860
ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
ClC-2 chloride secretion media ...... schemia-injured porcine ileum.
@en
ClC-2 chloride secretion media ...... schemia-injured porcine ileum.
@nl
type
label
ClC-2 chloride secretion media ...... schemia-injured porcine ileum.
@en
ClC-2 chloride secretion media ...... schemia-injured porcine ileum.
@nl
prefLabel
ClC-2 chloride secretion media ...... schemia-injured porcine ileum.
@en
ClC-2 chloride secretion media ...... schemia-injured porcine ileum.
@nl
P2093
P1433
P1476
ClC-2 chloride secretion media ...... ischemia-injured porcine ileum
@en
P2093
Bruce D Schultz
Dianne Little
Donnie E Shifflett
Melissa M Haskell
P304
P356
10.1053/J.GASTRO.2004.06.004
P407
P577
2004-09-01T00:00:00Z